Why Kroger’s GLP-1 Move Matters For Stock Watchers

Kroger (KR) is putting more weight behind healthcare services through its new GLP-1 Complete Support Program, linking pharmacy, dietitians and clinical care for patients using GLP-1 weight management medications.

For investors tracking Kroger stock, the launch highlights how the company is using its health division, in store clinics and digital tools to tie recurring prescription activity to its broader grocery and nutrition ecosystem.

Even with the GLP-1 Complete Support launch drawing attention to Kroger’s health offering, the stock’s recent 30 day share price return of 2.75% and 90 day share price decline of 15.41% show fading momentum. At the same time, the 5 year total shareholder return of 55.44% underlines how longer term holders have seen a very different experience.

If this kind of health focused story has you thinking more broadly about where to put fresh capital, it could be worth scanning companies in other growth themes using the 39 healthcare AI stocks

Kroger’s GLP-1 Complete Support launch, recent share price pullback and a market value of about US$34.2b set up a simple tension: is more of the opportunity already in the rear view mirror, or still in front of the stock?

Most Popular Narrative: 19.6% Undervalued

The most followed Kroger narrative pegs fair value at $70.71 per share versus a last close of $56.87, framing the current price as a discount to its longer term earnings and cash flow potential under a turnaround plan.

The rapid growth in Kroger's e commerce business, highlighted by a 15% YoY increase and strong improvements in delivery, suggests significant upside potential as more consumers shift to online grocery shopping. Ongoing investment in unified digital platforms and fulfillment operations is expected to support future revenue growth and contribute to profit improvement as the business scales.

Want to see what kind of revenue mix, margin rebuild and future profit multiple are reflected in that fair value story, and how much depends on e commerce scaling, private label strength and fresh format expansion?

Result: Fair Value of $70.71 (UNDERVALUED)

However, Kroger’s unprofitable e commerce operations and ongoing store closures highlight that execution missteps on digital scaling or footprint reshaping could easily unsettle this undervalued narrative.

Another View: Kroger On Earnings Multiples

The main Kroger story so far leans on future cash flows and analyst targets, but the current P/E of 33.3x tells a different story. That is higher than the US Consumer Retailing industry at 20.4x, the peer average of 26.1x, and the fair ratio of 31.5x, which suggests less margin for error if growth or execution slip.

For many investors, the question becomes simple: does paying a higher P/E than the industry, peers, and even the fair ratio still feel comfortable if Kroger’s turnaround takes longer than expected, or is this where valuation risk starts to matter more than the DCF upside?

Next Steps

If this mix of opportunity and concern around Kroger has you thinking harder about where the balance really sits, move quickly to check both sides of the story and weigh the 4 key rewards and 4 important warning signs

Looking For More Investment Ideas Beyond Kroger?

If Kroger has sharpened your focus, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.

• Target growth potential in overlooked corners of the market by scanning 21 elite penny stocks with strong financials, which already show stronger financial footing than many tiny peers.
• Hunt for quality at a price that could make more sense by checking companies flagged in the screener containing 20 high quality undiscovered gems before they attract wider attention.
• Prioritize resilience and sleep better at night by zeroing in on businesses highlighted in the 81 resilient stocks with low risk scores that score well on financial stability and risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.